• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Novira Therapeutics

edit

Novira is focused on the discovery and development of first-in-class antiviral therapeutics. Based on emerging biology and proprietary insights on virus-host interactions, the company is working to develop novel small molecule drugs against medically-important viral targets.

Recent Milestones

edit

• 
  Novira Therapeutics received $7.5M in Series A funding. (3/25/13)
  Posted 3/28/13 at 8:42pm via fiercebiotech.com
• 
  Novira Therapeutics received $23M in Series A funding. (8/24/12)
  Posted 8/24/12 at 4:53am via finsmes.com
• 
  Novira Therapeutics received $2.5M in Seed funding. (7/26/11)
  Posted 4/14/09 at 6:39am via noviratherapeutics.com

Videos

Screenshots

edit

Sources

1. Novira Therapeutics, Inc. Completes Second Round of Seed Financing with Philadelphia Angel Syndicate (noviratherapeutics.com) [edit]
2. Novira Therapeutics Secures $23M in Series A Financing (finsmes.com) [edit]
3. Versant adds $7.5M to upstart biotech's A round (fiercebiotech.com) [edit]